Kaluga eyes new site to produce FDA-approved innovation drugs
31 July 2013
The Kaluga region in Central Russia, the city of Kaluga and NovaMedica, a young Russian pharma, have agreed to build a new pharmaceutical factory in the area, Rusnano reports .
New Russian company to build $85M plant
30 July 2013
NovaMedica was formed out of Domain Associates' partnership with RUSNANO.
$85m Plant Demonstrates Russia's Commitment to Pharma 2020, says NovaMedica
29 July 2013
NovaMedica and the Russian Government are to build an $85m (€64m) facility as part of a joint venture encouraging local manufacturing, the company says.
26 July 2013
The Government of Kaluga Region, the Administrative Board of the City of Kaluga and NovaMedica pharmaceutical company (a subsidiary of RUSNANO and Domain Associates) have signed an agreement on the execution of an investment project to build a new pharmaceutical plant in the region.
NovaMedica Inks Pact to Build $85 Million Facility, 100 New Jobs Will be Created
26 July 2013
The Government of Kaluga Region, the Administrative Board of the City of Kaluga and NovaMedica pharmaceutical company (a subsidiary of RUSNANO and Domain Associates) have signed an agreement on the execution of an investment project to build a new pharmaceutical plant in the region.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024